| Tamás Ágh MD MSc PhD DrHabil graduated from the Semmelweis Medical University (MD, 2006), the Corvinus University of Budapest (MSc Physician-Economist, 2010), the Semmelweis University School of PhD Studies (PhD in Pharmacoeconomics, 2013) and the University of Pecs Doctoral School of Health Sciences (DrHabil in Health Sciences, 2020). He specialized in family medicine in 2010. Dr. Ágh is a principal researcher of Syreon Research Institute, a research fellow at the Center for Health Technology Assessment and Pharmacoeconomic Research, University of Pecs and has been practicing as a medical doctor since 2006. With 14 years of experience in health economics and outcome research, he developed expertise in the fields of PROs (i.e., medication adherence, quality of life), health technology assessment, and evidence synthesis. Dr. Ágh is a member of the leadership group of the ISPOR Medication Adherence and Persistence Special Interest Group and the leader of Working Group 3 in the European Network to Advance Best practices & technoLogy on medication adherencE (ENABLE) Cost Action. |
Tamás ÁGH
Principal researcher
| Work place: Syreon Research Institute Work address: 1142 Budapest, Mexikoi str. 65/A, Hungary |
| Email: tamas.agh@syreon.eu |